# Janux Therapeutics, Inc. (JANX): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Janux Therapeutics, Inc. (JANX) is 26/100, ranked against 24,000+ stocks in 35 markets (Quality 34, Value 32, Momentum 45, each scored against its sector).

- StockRank: 26/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 34, Value 32, Momentum 45: each a 0-100 percentile within Healthcare.
- Position: #19,636 overall, #1,729 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 16.69 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 86K.

Source: https://moatmap.ai/stock/JANX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker